Search results with tag "Illofacial"

Medication-Related Osteonecrosis of the Jaw—2014 Update

Oral and maxillofacial surgeons first recognized and reported cases of non-healing exposed bone in the max-illofacial region in patients treated with IV bisphospho-nates.24,25 In September 2004, Novartis, the manufacturer of the IV bisphosphonates pamidronate (Aredia®) and zoledronic acid (Zometa®), notified healthcare profession

  Medication, Related, Oral, Surgeons, Osteonecrosis, Maxillofacial, Medication related osteonecrosis, Oral and maxillofacial surgeons, Max illofacial, Illofacial